Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

inflammatory diseases

This page shows the latest inflammatory diseases news and features for those working in and with pharma, biotech and healthcare.

Roche enters NASH race with deal to buy Jecure

Roche enters NASH race with deal to buy Jecure

Feldstein – sits apart from rival therapies and could have applications beyond NASH in other inflammatory disorders gout including inflammatory bowel disease and cardiovascular diseases. ... We’re excited to combine Jecure’s portfolio with our

Latest news

  • NHS says Humira biosimilar deal will save £300m NHS says Humira biosimilar deal will save £300m

    Humira (adalimumab) is a TNF blocker used to treat inflammatory diseases such as rheumatoid arthritis, psoriasis and inflammatory bowel disease, and is currently the world’s top-selling medicine, adding more

  • Google boosts healthcare business with new hire Google boosts healthcare business with new hire

    Earlier this year, Google’s life science and healthcare division Verily teamed up with Gilead to develop a high-res molecular map of inflammatory diseases. ... This allows identification and characterisation of inflammatory disease mechanisms. Verily

  • First Humira biosimilars reach EU market First Humira biosimilars reach EU market

    Humira made $18bn in revenues last year – mostly in the US but with around $6bn from the rest of the world – and is widely used to treat a range of inflammatory ... diseases including rheumatoid arthritis, psoriasis and Crohn's disease.

  • BMS psoriasis drug hits the mark in phase II BMS psoriasis drug hits the mark in phase II

    presence than BMS in the inflammatory disease market.

  • Human Cell Atlas gets new UK funding Human Cell Atlas gets new UK funding

    Researchers say insights gained from the atlas could help to increase understanding of diseases such as asthma and cancer develop and progress, or point to new diagnostic tools and treatments. ... Creating a highly detailed atlas of the skin. A spotlight

More from news
Approximately 4 fully matching, plus 103 partially matching documents found.

Latest Intelligence

  • Innovation in merger control and the impact on the pharmaceutical sector Innovation in merger control and the impact on the pharmaceutical sector

    Specifically, Hospira was selling Inflectra, an infliximab biosimilar used to treat several chronic inflammatory diseases, notably the inflammation of Crohn’s disease, while Pfizer was in an advanced stage of developing

  • ‘How is your day?’ ‘How is your day?’

    Physicians need to be more aware of rare diseases that may hide behind recurring issues that some patients have. ... These are: Primary Immunodeficiency Diseases (PID – causes severe infections); Chronic Inflammatory Demyelinating Polyneuropathy (CIDP

  • The tipping point The tipping point

    In chronic diseases such as rheumatoid arthritis and inflammatory bowel disease, there are significantly greater savings from switching patients compared with initiating biosimilars in naïve patients alone.

  • Taking a lean and careful approach Taking a lean and careful approach

    Its fully human engineered CD3 antibody Foralumab has reached phase II with potential for a wide range of autoimmune and inflammatory diseases such as non-alcoholic steatohepatitis (NASH), primary biliary cholangitis, ... Database of diseases. The

  • Grünenthal's relentless pursuit of relief Grünenthal's relentless pursuit of relief

    It is a good fit strategically for us because it enriches our portfolio in the area of inflammatory and pain-related diseases with high unmet need. ... Pain has nervous and inflammatory components and we are interested in everything around the

More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

  • Infographic: Spondyloarthritis

    Overview of spondyloarthritis patient profiles and treatment pathways. Spondyloarthritis is the name for a family of arthritis causing inflammatory rheumatic diseases; including axial spondyloarthritis, psoriatic arthritis and akylosing spondylitis,

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is an award winning, independent, full service, creative communications agency specialising in solving problems for healthcare brands....

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Quick links

Infographics

Multimedia